🇺🇸 FDA
Patent

US 8617532

Therapeutic use of interferon-polymer conjugates

granted A61KA61K31/40A61K38/212

Quick answer

US patent 8617532 (Therapeutic use of interferon-polymer conjugates) held by PHARMAESSENTIA CORPORATION expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PHARMAESSENTIA CORPORATION
Grant date
Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/40, A61K38/212, A61K47/60, A61P